← Back to Clinical Trials
Recruiting NCT06779201

NCT06779201 Fasting Effects on Metabolism and Immunity Study in Human

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06779201
Status Recruiting
Phase
Sponsor Xuanwu Hospital, Beijing
Condition Fasting
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2024-09-01
Primary Completion 2027-10-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Fasting

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2024-09-01 with a primary completion date of 2027-10-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to investigate the effects of 1-week fasting but not prohibiting water drink on human immune function, metabolic indicators, and brain function in human, and to explore the underlying mechanisms of these changes from a multi-omics perspective and/or other ways.

Eligibility Criteria

Inclusion Criteria: 1. Age 18-65 years old, gender is not limited; 2. BMI≥18.5; 3. Can tolerate a certain degree of hunger; 4. Can voluntarily sign written informed consent. Exclusion Criteria: 1. Women planning pregnancy, pregnancy and breastfeeding; 2. Previous liver disease, chronic kidney disease, heart disease and cerebrovascular disease; 3. Suffering from acute infectious diseases or chronic wasting diseases; 4. Have used antibiotic drugs in the past 3 months, and have used prebiotic or probiotic supplements or products in the past month; 5. Participate in other clinical investigators within 3 months before enrollment in this study.

Contact & Investigator

Central Contact

Rui Li, MD

✉ ruili@mail.ccmu.edu.cn

📞 +86 10 83198650

Principal Investigator

Hongxing Wang, MD & PhD

PRINCIPAL INVESTIGATOR

Xuanwu Hospital, Beijing

Frequently Asked Questions

Who can join the NCT06779201 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Fasting. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06779201 currently recruiting?

Yes, NCT06779201 is actively recruiting participants. Contact the research team at ruili@mail.ccmu.edu.cn for enrollment information.

Where is the NCT06779201 trial being conducted?

This trial is being conducted at Beijing, China.

Who is sponsoring the NCT06779201 clinical trial?

NCT06779201 is sponsored by Xuanwu Hospital, Beijing. The principal investigator is Hongxing Wang, MD & PhD at Xuanwu Hospital, Beijing. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology